Neograft Technologies
Taunton
About Neograft Technologies
Neograft Technologies focuses on developing cardiac technologies for use in heart bypass procedures. The company's products include Angioshield, a device for the delivery of controlled temporary structural support to veins intended for use as arterial vein grafts. It was founded in 2009 and headquartered in Taunton, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $39.3M
- Last round: Series Unknown (Jan 2017)
- Website: neograftinc.com
- Phone: 7819877222
Industries & Categories
Health Care, Health Diagnostics, Manufacturing, Medical
Canonical: https://fsome.com/organization/neograft-technologies-149404 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.